Business Wire

TX-MAVENIR

11.3.2021 15:02:11 CET | Business Wire | Press release

Share
Mavenir Extends AI and Analytics Portfolio to Enable Mobile Network Optimization, Automation & Security

Mavenir, the industry’s only end-to-end cloud-native Network Software Provider and a leader in accelerating software network transformation for communications service providers (CSPs), announced today its extended Artificial Intelligence (AI) and Analytics portfolio to enable closed-loop automation and drive digital transformation.

AI and machine learning (ML) in mobile network infrastructure is expected to lower costs by automating functions that typically require human interaction and to speed new revenue generating service offerings, becoming increasingly important as edge, open radio access networks (Open RAN), and 5G cores get deployed.

Mavenir’s AI and Analytics portfolio includes solutions designed to analyze and derive inferences from vast amounts of unstructured data to automate networks, achieve cost savings, and build out 5G use cases. Many Industry 4.0 use cases such as Intelligent Video Analytics and AR/VR are enabled by 5G that require AI-driven inferences at the edge. Mavenir’s portfolio includes these AI-enabled applications for Network Automation, Intelligent Operations, EdgeAI, and Network Security.

1)

 

Network Automation: Mavenir’s RAN Intelligent Controller (RIC) and Network Data Analytics Function (NWDAF) follow the specifications introduced by the O-RAN Alliance and 3GPP and operate as the heart of a network automation vision. The RIC and NWDAF enable the network to dynamically adapt to traffic conditions using machine learning (ML)-based algorithms and applications that can be deployed in any network in a multi-vendor environment. Mavenir’s containerized RIC and NWDAF product capabilities include:

 

  • Non-RT RIC: designed to host advanced ML algorithms (rApps) to optimize network performance and train ML models using long-term RAN data for dynamic and adaptive policy for RAN performance optimization.
  • Near-RT RIC: designed to host trained AI/ML models (xApps) to infer and control O-RAN functional elements in near-real time.
  • NWDAF: designed to ingest data from 5G standalone (SA) network functions and to provide various analytics and intelligence services for smart network operation.

2)

 

Intelligent Operations: By automating network operational processes with AI and analytics solutions, operators should be able to substantially reduce the cost and time from traditional, more labor-intensive methods such as drive testing, log inspection, troubleshooting, and manual calibration. With AI-based prediction engines, operators can achieve intelligent capacity planning and reduce the possibility of large-scale network outages. With anomaly detection capability, operators can uncover underlying network faults that are not easily visible. This AI-driven Operations (AIOps) solution using ML techniques plays a key role in reducing operating expenses and gives operators complete control over their networks.

 

 

3)

 

5G EdgeAI : Mavenir’s 5G EdgeAI solution includes Intelligent Video Analytics that can support myriad of use cases from facial recognition to anomaly detection for smart city and industry 4.0 use cases. Next generation of AR/VR applications are accelerated and enhanced by this edge platform. Large number of sensor data gets analyzed and actions are taken in a matter of milliseconds by the edge Industrial Internet of Things (IIoT) analytics application.

 

 

 

“AI is the key driver for Industry 4.0, providing real-time insights & control of industrial processes. Low latency, high density of 5G are also enablers, so in essence, the combination of 5G and AI = Industry 4.0,” said Kuntal Chowdhury, SVP and GM, Mavenir AI and Analytics Business Unit. “While Mavenir’s AI and Analytics solutions are now available as standalone solutions, we have been offering intelligent insights as integrated solutions to Tier 1 customers around the world for years. Currently over 200 systems are deployed in more than 80 customer networks and our solutions process and analyze billions of records per day, offering real-time/near-real-time insights to optimize network performance with little to no human intervention.”

 

 

4)

 

Network security: As new vulnerabilities arise, Mavenir’s Fraud Management and Security Suite protect the network in real-time with predictive analytics and ML. The Real-Time Fraud Management and Security analytics is leveraging unique ML algorithms and a specifically designed framework suited to manage the volume, velocity, and variety of structured and unstructured data over wireless networks.

 

 

 

“Mavenir Security and Anti-Fraud Solutions based on AI/ML are taking care of on-going revenue savings at Telefónica Argentina,” says Diego Quevedo, Core Network Solution Design Lead, Telefónica Argentina. “We are in close cooperation with Mavenir to ensure the up-to-date protection of our network.”

 

 

 

“Mavenir’s approach of applying Real-Time Machine Learning technology to protect key operator services and revenue has been highly valued by customers,” said Ilia Abramov, VP and GM, Mavenir Security BU. “New threats raised in the recent years and increasing attack vectors on Mobile Network Services have been successfully detected and blocked though our installed base. The increased level of trust of our AI/ML technology has been confirmed with substantial growth in additional network implementations in the last year.”

“Leveraging our deep AI/ML knowledge and advanced capabilities enables Communications Service Providers to optimize, automate and advance their mobile networks for the future of 5G,” said BG Kumar, President, Mavenir’s Communications Services Business Group. “Network automation and service protection driven by AI/ML are core capabilities of Mavenir and one of the highest priorities of our customers, and we are proud to provide this solution set to enable them to realize their vision.”

Mavenir’s AI/ML and Analytics solutions and Fraud/Security solutions are deployed at multiple Tier 1 operator networks across North America, EMEA, and APAC regions. Additionally, Mavenir is dedicated to continuous AI/ML innovation through the R&D Center of Excellence in Brno, Czech Republic, and R&D in Richardson TX and Bangalore, India.

About Mavenir:

Mavenir is the industry's only end-to-end, cloud-native Network Software and Solutions/Systems Integration Provider, focused on accelerating software network transformation. Mavenir offers a comprehensive end-to-end product portfolio across every layer of the network infrastructure stack for communications service providers and enterprises. From 5G application layers (VoLTE, Messaging) to Packet Core and RAN, Security, Edge Analytics and AI, Mavenir leads the way in evolved, cloud-native networking solutions enabling innovative and secure experiences for end users.

Leveraging innovations in Mobile Core with IMS (VoLTE, VoWiFi, Advanced Messaging/RCS), and Packet Core (vEPC, 5G Core) as well as Radio Access/Edge (OpenRAN), Private Networks, as well as Mobile Services and Applications such as Digital Enablement. Mavenir accelerates digital network transformation for more than 250+ CSP customers in over 120 countries, which serve over 50% of the world’s subscribers. www.mavenir.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye